Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line

World Journal of Gastroenterology

Volumn 12, Issue 26, 2006, Pages 4137-4142

  Tian, Ying ^a   Song, Yang ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cell proliferation; Colonic neoplasms; Phytic acid

Indexed keywords

PHYTIC ACID; PROTEIN P21; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN HT29; COLON CARCINOMA; CONCENTRATION PROCESS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 33748583748     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i26.4137     Document Type: Article

References (40)

1. Steinert R, Buschmann T, van der Linden M, Fels LM, Lippert H, Reymond MA. The role of proteomics in the diagnosis and outcome prediction in colorectal cancer. Technol Cancer Res Treat 2002; 1: 297-304
2. Price AS. Primary and secondary prevention of colorectal cancer. Gastroenterol Nurs 2003; 26: 73-81
3. Zhang YZ, Li SY. New technologies of early diagnosis on colorectal cancer. Shijie Huaren Xiaohua Zazhi 2004; 12: 1202-1205
4. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD. Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am J Epidemiol 1994; 139: 1-15
5. Greenwald P, Lanza E, Eddy GA. Dietary fiber in the reduction of colon cancer risk. J Am Diet Assoc 1987; 87: 1178-1188
6. Helzlsouer KJ, Block G, Blumberg J, Diplock AT, Levine M, Marnett LJ, Schulplein RJ, Spence JT, Simic MG. Summary of the round table discussion on strategies for cancer prevention: diet, food, additives, supplements, and drugs. Cancer Res 1994; 54: 2044s-2051s
7. Howe GR, Benito E, Castelleto R, Cornee J, Esteve J, Gallagher RP, Iscovich JM, Deng-ao J, Kaaks R, Kune GA. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 1992; 84: 1887-1896
8. Slavin J, Jacobs D, Marquart L. Whole-grain consumption and chronic disease: protective mechanisms. Nutr Cancer 1997; 27: 14-21
9. Barbolt TA, Abraham R. The effect of bran on dimethylhydrazine-induced colon carcinogenesis in the rat. Proc Soc Exp Biol Med 1978; 157: 656-659
10. Barbolt TA, Abraham R. Dose-response, sex difference, and the effect of bran in dimethylhydrazine-induced intestinal tumorigenesis in rats. Toxicol Appl Pharmacol 1980; 55: 417-422
11. Reddy BS, Mori H. Effect of dietary wheat bran and dehydrated citrus fiber on 3,2′-dimethyl-4-aminobiphenyl-induced intestinal carcinogenesis in F344 rats. Carcinogenesis 1981; 2: 21-25
12. Alabaster O, Tang Z, Frost A, Shivapurkar N. Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 1995; 16: 127-132
13. McIntyre A, Gibson PR, Young GP. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 1993; 34: 386-391
14. Alabaster O, Tang ZC, Frost A, Shivapurkar N. Potential synergism between wheat bran and psyllium: enhanced inhibition of colon cancer. Cancer Lett 1993; 75: 53-58
15. Eastwood MA. The physiological effect of dietary fiber: an update. Annu Rev Nutr 1992; 12: 19-35
16. Weisburger JH, Reddy BS, Rose DP, Cohen LA, Kendall ME, Wynder EL. Protective mechanisms of dietary fibers in nutritional carcinogenesis. Basic Life Sci 1993; 61: 45-63
17. Velazquez OC, Lederer HM, Rombeau JL. Butyrate and the colonocyte. Implications for neoplasia. Dig Dis Sci 1996; 41: 727-739
18. Graf E, Eaton JW. Dietary suppression of colonic cancer. Fiber or phytate? Cancer 1985; 56: 717-718
19. Harland BF, Oberleas D. Phytate in foods. World Rev Nutr Diet 1987; 52: 235-259
20. Johnson LF, Tate ME. Structure of "phytic acids". Can J Chem 1969; 47: 63-73
21. Mills BJ, Broghamer WL, Higgins PJ, Lindeman RD. Inhibition of tumor growth by zinc depletion of rats. J Nutr 1984; 114: 746-752
22. Bunce CM, French PJ, Allen P, Mountford JC, Moor B, Greaves MF, Michell RH, Brown G. Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts. Biochem J 1993; 289 (Pt 3): 667-673
23. Grases F, Simonet BM, Prieto RM, March JG. Phytate levels in diverse rat tissues: influence of dietary phytate. Br J Nutr 2001; 86: 225-231
24. Shamsuddin AM, Vucenik I, Cole KE. IP6: a novel anti-cancer agent. Life Sci 1997; 61: 343-354
25. Shamsuddin AM. Inositol phosphates have novel anticancer function. J Nutr 1995; 125: 725S-732S
26. Warbrick E. PCNA binding through a conserved motif. Bioessays 1998; 20: 195-199
27. Lehmann AR. Dual functions of DNA repair genes: molecular, cellular, and clinical implications. Bioessays 1998; 20: 146-155
28. Kelman Z. PCNA: structure, functions and interactions. Oncogene 1997; 14: 629-640
29. Cayrol C, Knibiehler M, Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 1998; 16: 311-320
30. Aranda FI, Laforga JB. Cellular proliferation in breast ductal infiltrating carcinoma. Correlation with clinical and histopathological variables. Pathol Res Pract 1997; 193: 683-688
31. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-168
32. Cox LS, Lane DP. Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 1995; 17: 501-508
33. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-967
34. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-810
35. Culotta E, Koshland DE Jr. p53 sweeps through cancer research. Science 1993; 262: 1958-1961
36. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990; 87: 7555-7559
37. Saied IT, Shamsuddin AM. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res 1998; 18: 1479-1484
38. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331
39. Malkowicz SB, Tomaszewski JE, Linnenbach AJ, Cangiano TA, Maruta Y, McGarvey TW. Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas. Oncogene 1996; 13: 1831-1837
40. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-704